Keywords
Last Name
Institution

Roger Lewis White

Title
InstitutionMedical University of South Carolina
DepartmentSCCP Clinical Pharmacy and Outcome Sciences - MUSC Campus
AddressP.O. Box MSC140
QF219
280 Calhoun St.
Phone843-792-8462
Fax843-792-1712
vCardDownload vCard

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Enzweiler KA, Bosso JA, White RL. A novel method of estimating cost of therapy by using patient population characteristics: analysis of fluoroquinolones in various populations with different distributions of renal function. Pharmacotherapy. 2003 Jul; 23(7):925-32. PMID: 12885105.
      View in: PubMed
    2. White RL, Bonapace CR, Friedrich LV, Rybak MJ, Cappelletty DM, Mercier RC, Houlihan HH, Aeschlimann JR, Bosso JA. Assessment of differences in antimicrobial effect determined with two in vitro pharmacodynamic models: impact of surface area to volume ratio. Pharmacotherapy. 2003 May; 23(5):603-8. PMID: 12741434.
      View in: PubMed
    3. Bonapace CR, Bosso JA, Friedrich LV, White RL. Comparison of methods of interpretation of checkerboard synergy testing. Diagn Microbiol Infect Dis. 2002 Dec; 44(4):363-6. PMID: 12543542.
      View in: PubMed
    4. Bonapace CR, Friedrich LV, Bosso JA, White RL. Determination of antibiotic effect in an in vitro pharmacodynamic model: comparison with an established animal model of infection. Antimicrob Agents Chemother. 2002 Nov; 46(11):3574-9. PMID: 12384367; PMCID: PMC128701.
    5. Bonapace CR, White RL, Frich LV, Bosso JA. Differences in antimicrobial drug exposure in patients with various degrees of renal function based on recommendations from dosing references. Pharmacotherapy. 2002 Sep; 22(9):1097-104. PMID: 12222544.
      View in: PubMed
    6. White RL, Enzweiler KA, Friedrich LV, Wagner D, Hoban D, Bosso JA. Comparative activity of gatifloxacin and other antibiotics against 4009 clinical isolates of Streptococcus pneumoniae in the United States during 1999-2000. Diagn Microbiol Infect Dis. 2002 Jul; 43(3):207-17. PMID: 12106954.
      View in: PubMed
    7. White RL. Antibiotic resistance: where do ketolides fit? Pharmacotherapy. 2002 Jan; 22(1 Pt 2):18S-29S; discussion 30S-32S. PMID: 11791625.
      View in: PubMed
    8. White RL. What in vitro models of infection can and cannot do. Pharmacotherapy. 2001 Nov; 21(11 Pt 2):292S-301S. PMID: 11714221.
      View in: PubMed
    9. White RL, Friedrich LV, Burgess DS, Brown EW, Scott LE. Effect of removal of duplicate isolates on cumulative susceptibility reports. Diagn Microbiol Infect Dis. 2001 Apr; 39(4):251-6. PMID: 11404069.
      View in: PubMed
    10. White RL, Friedrich LV, Manduru M, Mihm LB, Bosso JA. Comparative in vitro pharmacodynamics of imipenem and meropenem against ATCC strains of Escherichia coli, Staphylococcus aureus and Bacteroides fragilis. Diagn Microbiol Infect Dis. 2001 Jan; 39(1):39-47. PMID: 11173190.
      View in: PubMed
    11. Bonapace CR, White RL, Friedrich LV, Bosso JA. Evaluation of antibiotic synergy against Acinetobacter baumannii: a comparison with Etest, time-kill, and checkerboard methods. Diagn Microbiol Infect Dis. 2000 Sep; 38(1):43-50. PMID: 11025183.
      View in: PubMed
    12. White RL, Friedrich LV, Mihm LB, Bosso JA. Assessment of the relationship between antimicrobial usage and susceptibility: differences between the hospital and specific patient-care areas. Clin Infect Dis. 2000 Jul; 31(1):16-23. PMID: 10913390.
      View in: PubMed
    13. Bonapace CR, White RL, Friedrich LV, Norcross ED, Bosso JA. Pharmacokinetics of cefepime in patients with thermal burn injury. Antimicrob Agents Chemother. 1999 Dec; 43(12):2848-54. PMID: 10582870; PMCID: PMC89575.
    14. Friedrich LV, White RL, Bosso JA. Impact of use of multiple antimicrobials on changes in susceptibility of gram-negative aerobes. Clin Infect Dis. 1999 May; 28(5):1017-24. PMID: 10452628.
      View in: PubMed
    15. Bosso JA, Bonapace CR, Flume PA, White RL. A pilot study of the efficacy of constant-infusion ceftazidime in the treatment of endobronchial infections in adults with cystic fibrosis. Pharmacotherapy. 1999 May; 19(5):620-6. PMID: 10331825.
      View in: PubMed
    16. Manduru M, Mihm LB, White RL, Friedrich LV, Flume PA, Bosso JA. Comparative bactericidal activity of ceftazidime against isolates of Pseudomonas aeruginosa as assessed in an in vitro pharmacodynamic model versus the traditional time-kill method. Antimicrob Agents Chemother. 1997 Nov; 41(11):2527-32. PMID: 9371361; PMCID: PMC164156.
    17. Manduru M, Mihm LB, White RL, Friedrich LV, Flume PA, Bosso JA. In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients. Antimicrob Agents Chemother. 1997 Sep; 41(9):2053-6. PMID: 9303416; PMCID: PMC164067.
    18. Manduru M, Fariello A, White RL, Fox JL, Bosso JA. Stability of ceftazidime sodium and teicoplanin sodium in a peritoneal dialysis solution. Am J Health Syst Pharm. 1996 Nov 15; 53(22):2731-4. PMID: 8931816.
      View in: PubMed
    19. Berg PH, Voit EO, White RL. A pharmacodynamic model for the action of the antibiotic imipenem on Pseudomonas aeruginosa populations in vitro. Bull Math Biol. 1996 Sep; 58(5):923-38. PMID: 8837524.
      View in: PubMed
    20. White RL, Burgess DS, Manduru M, Bosso JA. Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother. 1996 Aug; 40(8):1914-8. PMID: 8843303; PMCID: PMC163439.
    21. Nicolau DP, White RL, Friedrich LV, Kays MB. The costs of burn care: an analysis with an emphasis on the use of parenteral antimicrobials. J Burn Care Rehabil. 1994 May-Jun; 15(3):244-50. PMID: 8056815.
      View in: PubMed
    22. White RL, Kays MB, Friedrich LV, Del Bene VE. Impact of different statistical methodologies on the evaluation of the in-vitro MICs for Bacteroides fragilis of selected cephalosporins and cephamycins. J Antimicrob Chemother. 1993 Jan; 31(1):57-64. PMID: 8444675.
      View in: PubMed
    23. Friedrich LV, White RL, Kays MB, Burgess DS. Pharmacoeconomic evaluation of treatment of penetrating abdominal trauma. Am J Hosp Pharm. 1992 Mar; 49(3):590-4. PMID: 1598932.
      View in: PubMed
    24. Kays MB, White RL, Gatti G, Gambertoglio JG. Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations. Pharmacotherapy. 1992; 12(1):50-5. PMID: 1549539.
      View in: PubMed
    25. Kays MB, White RL, Friedrich LV, Del Bene VE. Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties. Clin Ther. 1991 Sep-Oct; 13(5):596-605. PMID: 1799917.
      View in: PubMed
    26. Uber WE, Brundage RC, White RL, Brundage DM, Bromley HR. In vivo inactivation of tobramycin by piperacillin. DICP. 1991 Apr; 25(4):357-9. PMID: 1926903.
      View in: PubMed
    27. White RL, Kays MB, Friedrich LV, Brown EW, Koonce JR. Pseudoresistance of Pseudomonas aeruginosa resulting from degradation of imipenem in an automated susceptibility testing system with predried panels. J Clin Microbiol. 1991 Feb; 29(2):398-400. PMID: 1822083; PMCID: PMC269776.
    28. Friedrich LV, White RL, Kays MB, Brundage DM, Yarbrough D. Aztreonam pharmacokinetics in burn patients. Antimicrob Agents Chemother. 1991 Jan; 35(1):57-61. PMID: 2014982; PMCID: PMC244941.
    29. Friedman RJ, Friedrich LV, White RL, Kays MB, Brundage DM, Graham J. Antibiotic prophylaxis and tourniquet inflation in total knee arthroplasty. Clin Orthop Relat Res. 1990 Nov; (260):17-23. PMID: 2121406.
      View in: PubMed
    30. White RL, Kays MB, Armstrong TA, Friedrich LV. Effects of supraphysiologic temperature and broth dilution on serum protein binding. Antimicrob Agents Chemother. 1990 Jun; 34(6):1257-8. PMID: 2393287; PMCID: PMC171795.
    31. Friedrich LV, White RL, Brundage DM, Kays MB, Friedman RJ. The effect of tourniquet inflation on cefazolin tissue penetration during total knee arthroplasty. Pharmacotherapy. 1990; 10(6):373-7. PMID: 2287555.
      View in: PubMed
    32. Friedrich LV, White RL, Reboli AC. Pharmacodynamics of trimethoprim-sulfamethoxazole in Listeria meningitis: a case report. Pharmacotherapy. 1990; 10(4):301-4. PMID: 2117750.
      View in: PubMed
    33. White RL, Nightingale CH, Quintiliani R, Whitaker KF, Jones RF, Tripp WH. Serum and tissue concentrations of cefoxitin and cefotaxime in women undergoing hysterectomy. Drugs. 1988; 35 Suppl 2:72-7. PMID: 3396492.
      View in: PubMed
    34. Marchbanks CR, Yost RL, White RL. Cefotaxime stability during in vitro microbiological testing. Antimicrob Agents Chemother. 1987 Sep; 31(9):1375-8. PMID: 3314698; PMCID: PMC174945.
    White's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _